Efficacy and Safety of LY01011 and Xgeva® in Patients With Bone Metastases From Solid Tumors

NCT04859569 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

850

Enrollment

INDUSTRY

Sponsor class

Conditions

Bone Metastases From Solid Tumors

Interventions

DRUG: LY01011
DRUG: Xgeva®

Sponsor

Luye Pharma Group Ltd.